Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Tirzepatide's dual GIP/GLP-1)
Injectables In a seminal March 2021 New England Journal of Medicine study, adults receiving a weekly 2.4 mg injection of semaglutide for about 15 months lost 15% of their body weight 35 pounds, on average
Adjustments occur when appropriate
While clinical trials show that this dual action is associated with greater weight loss, researchers are still evaluating the independent role of GIP agonism in those outcomes
US$ 27.47
US$ 29.61
US$ 22.38
US$ 21.09
US$ 27.88
US$ 26.16
US$ 24.39
US$ 20.18
US$ 26.48
